春节将近，春节档作为全年流量最大、竞争最激烈的黄金档期，一直是头部影视公司推出年度重磅影片的必争之地。值得关注 的是，2026年春节档长达9天，创下史上最长春节档纪录。 今年一共有8部电影定档春节档，影片题材丰富，涵盖喜剧、谍战、犯罪、动画、奇幻、家庭、纪录片等类型。还有沈腾、易烊 千玺、王鹤棣等知名演员扎堆加盟。 据猫眼专业版上映日历，除了纪录片《重返.狼群》于2月19日重映，黄子华、郑秀文等港星主演的喜剧电影《夜王》于2月20日 在两广(广东、广西)地区限定上映外，其他6部影片均定档大年初一(2月17日)上映。 8部影片云集春节档《惊蛰无声》想看人数暂列第一 据灯塔专业版数据，目前《惊蛰无声》想看人数暂列第一，与《飞驰人生3》《镖人：风起大漠》构成这个春节档的头部主力阵 营，《熊出没.年年有熊》《星河入梦》及《熊猫计划之部落奇遇记》则各守类型基本盘。 灯塔专业版6日发布的《2026年春节档前瞻》显示，《惊蛰无声》年轻及女性观众"想看"占比突出；《镖人：风起大漠》更吸引 男性观众；《熊出没.年年有熊》三四线城市"想看"占比断层领先；《飞驰人生3》和《熊猫计划之部落奇遇记》则分别是25至29 岁和40岁以上观 ...

春节将近，春节档作为全年流量最大、竞争最激烈的黄金档期，一直是头部影视公司推出年度重磅影片的必争之地。值得关注 的是，2026年春节档长达9天，创下史上最长春节档纪录。 今年一共有8部电影定档春节档，影片题材丰富，涵盖喜剧、谍战、犯罪、动画、奇幻、家庭、纪录片等类型。还有沈腾、易烊 千玺、王鹤棣等知名演员扎堆加盟。 春节档是一年中最重要的档期之一，灯塔专业版分析称，中国影史单日票房TOP5中，有4次出现在大年初一。业内专家指出， 近年来，春节档的马太效应将愈加明显，头部影片预计将贡献超过70%的票房。 据猫眼专业版上映日历，除了纪录片《重返·狼群》于2月19日重映，黄子华、郑秀文等港星主演的喜剧电影《夜王》于2月20日 在两广（广东、广西）地区限定上映外，其他6部影片均定档大年初一（2月17日）上映。 8部影片云集春节档 《惊蛰无声》想看人数暂列第一 据灯塔专业版数据，目前《惊蛰无声》想看人数暂列第一，与《飞驰人生3》《镖人：风起大漠》构成这个春节档的头部主力阵 营，《熊出没·年年有熊》《星河入梦》及《熊猫计划之部落奇遇记》则各守类型基本盘。 灯塔专业版6日发布的《2026年春节档前瞻》显示，《惊蛰无声》年轻 ...

诺和诺德全球高级副总裁兼大中国区总裁周霞萍表示："诺易特®上市并纳入医保，是诺和诺德深耕中 国罕见病领域的重要成果。从诺其®、诺易®到诺易特®，诺和诺德将持续为中国血友病患者提供优质 方案，逐步提高患者的药物可及性，不断完善患者服务体系，助力'健康中国2030'目标实现。" （文章来源：21世纪经济报道） 自2019年在美国获批上市以来，诺易特®在全球积累了丰富的预防和治疗出血的疗效和安全性数据。在 中国血友病A患者中进行的多中心试验Pathfinder105 结果显示，诺易特®接受预防治疗的患者中位年化 近日，全球领先的生物制药公司诺和诺德宣布，注射用培妥罗凝血素α（商品名：诺易特®）在中国大 陆正式上市。诺易特®是我国首个且目前唯一*获批的长效重组凝血因子Ⅷ，且已成功被新版国家医保 目录新增纳入。诺易特®在中国大陆市场的全面上市填补了血友病A长效治疗的空白，进一步提升了患 者用药的可及性，将中国血友病A患者带入全新治疗阶段。 出血率（ABR）为0.00，零出血患者比例高达69.4%，治疗出血的止血成功率为94.8%，为中国血友病A 患者提供高效便捷的治疗选择。 诺易特®适用于12岁及以上血友病A（先天性凝 ...

Market Performance - A-shares opened high and continued to rise, with the Shanghai Composite Index up 1.17%, the Shenzhen Component Index up 2.07%, and the ChiNext Index up 3.11% as of midday [1][4] - The total trading volume in the Shanghai and Shenzhen markets reached 1.5 trillion yuan, with over 4,400 stocks rising [1] Sector Highlights - The computing hardware industry chain experienced a significant surge, with CPO and storage sectors leading the gains [2] - The photovoltaic industry chain showed strong performance, with multiple stocks hitting the daily limit, including GCL-Poly Energy (002506) with four consecutive limits and Shuangliang Eco-Energy (600481) with three limits in five days [2] - AI applications and semiconductor sectors also saw notable increases, driven by breakthroughs in multimodal AI technology, particularly the launch of ByteDance's video generation model Seedance 2.0 [2][3] Stock Performance - Notable stock performances included Tianfu Communication (300394) and Guangku Technology (300620), both hitting the daily limit with a 20% increase [3] - Other significant gainers included Taicheng Light (140.41, up 16.27%), Shijia Photon (89.06, up 13.24%), and Changxin Bochuang (171.72, up 11.72%) [3] Precious Metals - Guotou Silver LOF rebounded after hitting the limit down, with a peak increase of over 8% before settling at over 6% [6] - Internationally, spot gold and silver prices rose sharply, with gold surpassing $5,040 per ounce and silver approaching $81 per ounce, reflecting a strong upward trend in precious metals [6]

近日，全球领先的生物制药公司诺和诺德宣布，注射用培妥罗凝血素α(商品名：诺易特)在中国大陆正 式上市。诺易特是我国首个且目前唯一*获批的长效重组凝血因子Ⅷ，且已成功被新版国家医保目录新 增纳入。诺易特在中国大陆市场的全面上市填补了血友病A长效治疗的空白，进一步提升了患者用药的 可及性，将中国血友病A患者带入全新治疗阶段。 血友病是一种X染色体连锁的隐性遗传性出血性疾病，可分为血友病A和血友病B两种。其中，血友病A 为凝血因子Ⅷ(FⅧ)缺乏，其患者约占所有血友病患者中的80%-85%，需终生用药，如不及时治疗，会 导致残疾，严重时甚至危及生命。随着治疗手段的不断进步，研究显示越来越多患者期待长效凝血因子 降低注射次数。 自2019年在美国获批上市以来，诺易特在全球积累了丰富的预防和治疗出血的疗效和安全性数据。在中 国血友病A患者中进行的多中心试验Pathfinder105结果显示，诺易特接受预防治疗的患者中位年化出血 率(ABR)为0.00，零出血患者比例高达69.4%，治疗出血的止血成功率为94.8%，为中国血友病A患者提 供高效便捷的治疗选择。 诺易特适用于12岁及以上血友病A(先天性凝血因子Ⅷ缺乏)患者， ...

Group 1 - The A-share market experienced a positive trend on February 9, with the Shanghai Composite Index rising over 1% to surpass 4100 points, and more than 4500 stocks in the market increasing in value [1] - The CSI All Share Securities Companies Index (399975.SZ) rose by 0.73%, with notable increases in stocks such as Jinlong Co., Ltd. rising over 4% and Caitong Securities rising over 2% [1] - Major securities firms like Huatai Securities and Industrial Securities saw their stocks increase by over 1%, indicating a broad-based rally in the securities sector [1] Group 2 - The Securities ETF (159841) recorded a trading volume of 159 million yuan, with a real-time discount rate of 0.07% [2] - The ETF saw a net inflow of 22.616 million yuan on the previous trading day (February 6), with a cumulative net inflow exceeding 1 billion yuan over the past 20 days [2] - As of February 6, the ETF had a latest circulating share count of 9.982 billion shares and a total circulating scale of 10.714 billion yuan, closely tracking the CSI All Share Securities Companies Index [2] Group 3 - Open Source Securities highlighted that by January 2026, the market's account openings, trading volume, and new fund issuance are expected to show significant year-on-year growth, benefiting brokerage firms and the securities IT sector [2] - GF Securities noted a continuous trend of incremental capital entering the market, suggesting that the undervalued brokerage sector could see amplified elasticity amid the spring market rally [2] - The stability of the capital market enhances the tool-like attributes of the brokerage sector, indicating a favorable outlook for the industry [2]

Core Viewpoint - The gas turbine sector is experiencing rapid growth, driven by an increased demand for energy solutions in North America, particularly due to a projected power shortfall in data centers from 44 GW to 47 GW between 2025 and 2028, equivalent to the total electricity consumption of 9 Miami or 15 Philadelphia [1][2] Group 1: Market Performance - Gas turbine concept stocks surged, with Linde Co. hitting the daily limit, and other companies like Yingliu Co. rising over 9% [1] - Several companies, including Jereh and Boying Special Welding, have been the focus of intensive research by multiple brokerages and fund companies [1] Group 2: Industry Insights - The gas turbine industry chain includes key components such as blades, casings, and combustion chambers, with domestic manufacturers like Yingliu Co., Haomai Technology, Feiwo Technology, and Wanze Co. making significant breakthroughs [2] - Jereh has entered the North American data center energy system integration market, providing complete power generation solutions and securing orders worth hundreds of millions from AI clients [2] - The current supply-demand tension is opening up overseas opportunities for Chinese gas turbine manufacturers like Dongfang Electric, Shanghai Electric, and Harbin Electric [2] - The demand for heat recovery steam generators (HRSG) is also increasing alongside gas turbines, with companies like Boying Special Welding, Xizi Clean Energy, Binglun Environment, and Changbao Co. being noteworthy players [2]

恒生指数涨1.57%，恒生科技指数涨1.44%。科网股集体反弹，小鹏汽车、哔哩哔哩、华虹半导体涨逾 4%，百度集团涨逾3%，中芯国际、阿里巴巴、京东集团、商汤等涨超2%。半导体板块拉升，澜起科技 上市首日高开57%，兆易创新、纳芯微涨超4%。 2月9日，亚太主要股指集体高开，截至9:58，上证指数涨0.98%，创业板指涨1.78%。光伏、算力硬件、 半导体、AI应用、商业航天、核聚变、黄金等概念股纷纷走强；油气、银行、中药板块走弱。 （文章来源：21世纪经济报道） 其中AI应用端大幅高开，传媒、短剧方向领涨，荣信文化、中文在线、海看股份、掌阅科技、风语 筑、欢瑞世纪涨停，流金科技、捷成股份、华策影视等涨幅靠前。 ...

市场概况 2月6日两市ETF两融余额为1212.7亿元，较前一交易日减少3.35亿元。其中融资余额为1137.31亿元，较前一交易日减少2.52亿元；融券余额为75.39亿元，较 前一交易日减少8261.64万元。 分市场来看，沪市ETF两融余额为852.03亿元，较前一交易日减少2.87亿元。其中融资余额为786.1亿元，较前一交易日减少2.3亿元；融券余额为65.93亿 元，较前一交易日减少5661.6万元。深市ETF两融余额为360.68亿元，较前一交易日减少4856.03万元。其中融资余额为351.22亿元，较前一交易日减少 2255.99万元；融券余额为9.46亿元，较前一交易日减少2600.04万元。 | 代码 | 基金名称 | | --- | --- | | 511380.SH | 博时中证可转债及可交换债 | | 518880.SH | 华安易富黄金ETF | | 513130.SH | 华泰柏瑞南方东英恒生科技指数 | | 511360.SH | 海富通中证短融ETF | | 510500.SH | 南方中证500ETF | | 159934.SZ | 易方达黄金ETF | | 513180 ...

南方财经2月9日电，港股保险股普涨，中国人寿、中国平安、中国太平、中国太保均涨超4%。 消息面 上，据国家金融监管总局最新披露数据显示，2025年保险业原保险保费收入约6.12万亿元，同比增长 7.43%。东吴证券指出，上市险企2026年"开门红"表现亮眼，当前"存款搬家"趋势延续，保险产品预定 利率仍高于银行存款，相对吸引力仍然明显，对全年新单保费增长持乐观预期，同时新单中分红险占比 预计进一步提升，利好险企负债成本持续改善。 方正证券：关注大权重、经营边际改善且股息率较高 的中国平安，投资弹性较大、业绩创新高的新华保险，业绩有望超预期的中国太平、中国人寿，业绩稳 健增长中国太保、中国人保，基本面延续改善的中国财险、众安在线等。 ...